Abstract: A neutron capture therapy system is provided, including a neutron generating device and a beam shaping assembly. The neutron capture therapy system further includes a concrete wall forming a space for accommodating the neutron generating device and the beam shaping assembly and shielding radiations generated by the neutron generating device and the beam shaping assembly. A support module is disposed in the concrete wall, the support module is capable of supporting the beam shaping assembly and is used to adjust the position of the beam shaping assembly, and the support module includes concrete and a reinforcing portion at least partially disposed in the concrete. The neutron capture therapy system designs a locally adjustable support for the beam shaping assembly, so that the beam shaping assembly can meet the precision requirement, improve the beam quality, and meet an assembly tolerance of the target.

Abstract: A wiping object cleaning device for a floor mopping machine belongs to the technical field of cleaning appliances. The wiping object cleaning device includes a bucket body, and further includes a water conveying mechanism for conveying water to a wiping object of a floor mopping machine. The water conveying mechanism conveys water during cleaning, and stops conveying water during water removal. The wiping object cleaning device is able to clean a mop of a floor mopping machine efficiently, wide in application range, suitable for different wiping objects of floor mopping machines, and low in production cost.

Abstract: A rotary connection structure includes a first external connection assembly and a rotation damping structure. The first external connection assembly is for external connection with a first photography device. The rotation damping structure includes a mounting member, a fastening member, and a connecting member. One end of the fastening member extends through the connecting member to fix and connect to the mounting member. The connecting member is rotatable, in a damped manner, about the fastening member. The connecting member is connected to the first external connection assembly. The first external connection assembly can be a clamp assembly. The mounting member is for connection with a second photography device. The second photography device can be a handgrip, and the handgrip is fixedly connected to the mounting member. The rotary connection structure proposed in the present invention realizes rotation of the first photography device and the second photography device.

Abstract: A photography kit is provided, which includes a first photography assembly including a first frame and a clamping assembly including two clamping bodies, a mounting seat, and a first locking assembly. The two clamping bodies are rotatably arranged on two opposite sides of the mounting seat. A connecting part is protruded at outside surfaces of the clamping bodies respectively. An end of the connecting part away from the clamping body is connected with a pressing part, which extends towards a rear end of the mounting seat, so that a pressing space is formed between the pressing part and the mounting seat. The first locking assembly is telescopically mounted to the mounting seat, a limiting part of the first locking assembly extends from the front end of the mounting seat, and the limiting part is configured for being inserted into a positioning hole correspondingly defined on the first frame.

Abstract: The present invention introduces ionic polymers featuring with a spiro structure, which enhances the solubility and gas permeability of the ionic polymer while maintaining excellent conductivity, mechanical properties, and dimensional stability. This is achieved by incorporating a spiro fragment with a large free volume into the polymer backbone. As a result, the gas permeability of the catalyst layer prepared from this ionic polymer is improved, making it suitable as a catalyst binder for proton exchange membrane fuel cells (PEMFCs) or anion exchange membrane fuel cells (AEMFCs). Furthermore, the electrochemical performance of the fuel cell is enhanced. Additionally, the proton exchange membrane and anion exchange membrane derived from this ionic polymer containing a spiro structure effectively improve the conductivity of both types of membranes by increasing the space volume due to the presence of the large free volume spiro fragment.

Abstract: Use of the active compound in the present disclosure for the prevention or treatment of ovarian dysfunction disease. In particular, the present disclosure relates to the use of a compound shown in Formula I or a pharmaceutically acceptable salt thereof in the treatment or prevention of ovarian dysfunction disease, wherein R1 and R2 are each independently selected from H, C1-C6 alkyl, C1-C6 alkenyl, and C1-C6 alkynyl. The present disclosure also relates to the use of a compound shown in said Formula I or a pharmaceutically acceptable salt thereof, in combination with hyodeoxycholic acid or a pharmaceutically acceptable salt thereof, in the treatment or prevention of ovarian dysfunction disease. The present disclosure also relates to compositions comprising a compound shown in said Formula I or a pharmaceutically acceptable salt thereof and/or hyodeoxycholic acid or a pharmaceutically acceptable salt thereof.

Abstract: A micro-fluxgate sensor has a double-iron core assembly, a self-oscillating module, a current superimposing and amplifying module and a voltage acquisition module. The double-iron core assembly comprises a first iron core and a second iron core. The first iron core is provided with a first winding coil. The second iron core is provided with a second winding coil. The first winding coil and the second winding coil are respectively connected with an input end of the self-oscillating module, and an output end of the self-oscillating module is respectively connected with the current superimposing and amplifying module and the voltage acquisition module. The fluxgate sensor is simple in processing circuit without manual debugging and is easily integrated.

Abstract: The invention disclosed herein relates to 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridinyl compounds and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridinyl compounds of Formula (A), pharmaceutical compositions comprising such compounds and the use of such compounds in the treatment of autoimmune diseases.

Abstract: An LED lamp includes: a lamp shell having a circular cross-section along a central axis of the lamp shell comprising a lamp neck and a sleeve; a heat sink comprising a plurality of fins, sleeving over the sleeve and connecting to the lamp neck; a power source comprising a power board and a plurality of electronic components mounted thereon disposed in the lamp neck and the sleeve; a light board comprising an opening at center portion and disposed at second end of the heat sink and physically and thermally connecting to the heat sink; a plurality of LED chips mounted on the light board and electrically connecting to the power source; and a lamp cover disposed at the second end of the heat sink and covering the plurality of LED chips; wherein the sleeve and the opening of the light board defines a first heat dissipating channel, the plurality of fins and the opening of the light board defines a second heat dissipating channel, the first heat dissipating channel and the second heat dissipating channel share the

Abstract: A method for generating a subtitle, an electronic device, and a computer-readable storage medium are provided. The method includes the following. A song audio signal is extracted from target video data. A target song corresponding to the song audio signal and a time position of the song audio signal in the target song are determined. Lyric information corresponding to the target song is obtained, where the lyric information includes one or more lyrics, and the lyric information further includes a starting time and duration of each lyric and/or a starting time and duration of each word in each lyric. A subtitle is rendered in the target video data based on the lyric information and time position to obtain target video data with a subtitle.

Abstract: Disclosed are an aroyl substituted tricyclic compound, a preparation method therefor and use thereof. Specifically, the aroyl substituted tricyclic compound of the present invention has a structure of formula (C), and has, as a BTK inhibitor, the advantages of high activity, good selectivity and low toxic and side effects.

Abstract: Embodiments of the disclosure provide a display substrate and a method for manufacturing the same. The display substrate includes: a base substrate; a thin film transistor including a source-drain metal layer and a first insulating layer; a second insulating layer; a color resist layer; and a third insulating layer. The third insulating layer comprises a first via hole that sequentially penetrates the third insulating layer, the color resist layer and the second insulating layer and thus extends from the third insulating layer to the source-drain metal layer. A sidewall of the first via hole comprises a first portion formed of a material of the second insulating layer, a second portion formed of a material of the color resist layer, and a third portion formed of a material of the third insulating layer, the second portion is between the first portion and the third portion.

Abstract: An LED light tube includes a glass tube, end caps, an LED light strip, LED light sources, and a power supply module. The end caps are respectively attached at two ends of the glass tube. The LED light strip is attached to an inner circumferential surface of the glass tube. The LED light sources are mounted on the LED light strip. The power supply module is electrically connected to the LED light strip. Each of the end caps includes a lateral wall and an end wall. The lateral wall is substantially coaxial with the glass tube and connected to the glass tube. The end wall is substantially perpendicular to an axial direction of the lateral wall and connected to an end of the lateral wall away from the glass tube. The power supply module includes a rectifying circuit and a filtering circuit electrically connected to the rectifying circuit.

Abstract: A LED lighting device includes a seat having a baseplate and a sidewall, the sidewall forming a chamber with the baseplate. A light source disposed in the chamber and attached to a surface of the baseplate. An electric power source is disposed in the chamber and electrically connected to the light source and an optical assembly is disposed on the light source. The optical assembly includes an optical unit and an installing unit, the installing unit is connected to a periphery of the optical unit. The optical unit includes a plurality of first optical members and a plurality of second optical members, and the second optical members are interposed between two adjacent first optical members. The installing unit includes a wall portion surrounding the sidewall, and the wall portion includes a bending portion abutting against an end of the sidewall.

Abstract: A neutron capture therapy system is provided, which may prevent a material of a beam shaping assembly from deformation and damaged, and improve the flux and quality of neutron sources. A boron neutron capture therapy system (100) includes a neutron generating device (10) and a beam shaping assembly (20). The neutron generating device (10) includes an accelerator (11) and a target (T). A charged particle beam (P) generated by acceleration of the accelerator (11) acts with the target (T) to generate neutrons. The neutrons form a neutron beam (N). The neutron beam (N) defines a main axis (X). The beam shaping assembly (20) includes a support part (21) and a main part (23) filled within the support part (21).

Abstract: A method includes: generating fault alarm information, and sending the fault alarm information through a serializer/deserializer (SerDes) bus. The fault alarm information indicates a fault that occurs in a first apparatus and/or a target communication link, and the target communication link is a link for communication between the first apparatus and a second apparatus.

Abstract: An LED light bulb is provided. The LED light bulb includes a lamp housing, a bulb base, a stem, two conductive supports, a driving circuit, and a flexible LED filament. The flexible filament includes a first LED section, a second LED section, a conductive section, a first conductive electrode, and a second conductive electrode. The first LED section is bent in a first three-dimensional curve shape. The second LED section is bent in a second three-dimensional curve shape. The conductive section includes a center point of the flexible LED filament. The flexible LED filament is bent in a third three-dimensional curve shape including the first three-dimensional curve shape, the conductive section, and the second three-dimensional curve shape.

Abstract: An LED filament comprising: a plurality of LED chips electrically connected with one another; two conductive electrodes, each of the two conductive electrodes being electrically connected to a corresponding LED chip of the LED chips; a light conversion coating coated on the two conductive electrodes, a portion of each of the two conductive electrodes being exposed from the light conversion coating, wherein the light conversion coating comprises a top layer and a base layer, the base layer coats on one side of the LED chips, and the top layer coats on another sides of the LED chips, so that the light conversion coating is coated on at least two sides of the LED chips; and the top layer comprise a wave crest and a wave trough adjacent to the wave crest, and an attaching structure disposed either between the top layer and the base layer, or between the base layer and the conductive electrodes, or between the top layer and the conductive electrodes to enhance fastness between the light conversion coating and the

Abstract: Provided is a pyridino- or pyrimido-cyclic compound having an inhibitory effect on a KRAS gene mutation, or a pharmaceutically acceptable salt, a stereoisomer or a solvate thereof, wherein the structure of the compound is as shown in formula (AI) or (AII), and the definition of each group in the formula is detailed in the description. In addition, also disclosed are a pharmaceutical composition comprising the compound, and the use thereof in the preparation of a cancer drug.